AwardTape · Defense awards · Medical · Diagnostics and lab supplies · HT942525F0013
HT942525F0013: $33K delivery order to Leinco Technologies, Inc
Leinco Technologies, Inc holds a delivery order from Defense Health Agency with $33K obligated since Oct 2023, against a ceiling of $33K. Latest action Oct 30, 2024.
Monoclonal antibodies from knockout mice who have been in-vivo genetically immunized with interferon-alpha/beta receptor alpha chain protein.
| PIID | HT942525F0013 |
|---|---|
| Type | delivery order |
| Parent award | HT942524D0009 |
| Company | Leinco Technologies, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $33K |
| Total obligated (lifetime) | $33K |
| Ceiling (base and all options) | $33K |
| Base date | Oct 30, 2024 |
| Latest action | Oct 30, 2024 |
| End date | Dec 30, 2024 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | MO |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial